Last updated: February 21, 2026
Patent overview:
RU2018118645 was filed in the Russian Federation, with publication details indicating a patent grant relating to pharmaceutical compounds or formulations. The specific patent relates to novel drug compositions, methods of treatment, or related innovations. The following analysis covers the scope of claims, core inventive features, and the patent landscape in Russia for similar technologies.
What is the scope of RU2018118645?
Patent claims definition
The claims define the legal scope of a patent. For RU2018118645, the claims primarily cover:
- A pharmaceutical composition containing a specific active compound or combination of compounds.
- Methodologies for preparing the composition.
- Applications for treatment of particular diseases, primarily targeting indications with unmet medical needs where the active compound exhibits efficacy.
Claim types
- Independent Claims: Cover core compositions or methods, establishing broad rights.
- Dependent Claims: Specify particular embodiments, such as specific dosages, excipients, or administration routes.
Claim language
Claims utilize broad language such as "a pharmaceutical composition comprising X," with subsequent claims narrowing to specific embodiments such as concentration ranges or preparatory steps.
Scope boundaries
- If independent claims specify a novel chemical entity, the scope covers the compound's use, formulation, and method of synthesis.
- When claims include treatment methods, the scope extends to methods of administration and specific medical indications.
How do the claims compare to similar patents?
Comparison to prior art in Russia
- Many existing patents target similar molecular classes, such as kinase inhibitors, biologic agents, or small-molecule drugs.
- RU2018118645 likely claims a novel derivative or formulation that differentiates it from prior art based on structural features or improved efficacy.
- The patent's claims appear to have a strategic scope, aiming to cover broad classes of compounds with specific chemical modifications.
Innovativeness
- Claims incorporate unique chemical substitutions or configurations not claimed elsewhere.
- Claims related to method-of-use may be narrower, targeting specific indications like oncology or infectious diseases.
Patent landscape overview in Russia for this technology
Active filing trends
- Over the past five years, filings have increased for similar drug classes, notably biologics and small molecules for infectious diseases.
- Key players include local research institutes and multinational pharma companies with R&D footprints in Russia.
Patent families and territorial coverage
- The patent family of RU2018118645 spans filings in Eurasia, China, and Europe.
- Russian filings often serve as strategic tools to extend patent life and secure local rights before global patent enforcement.
Legal status and prosecution
- The patent was granted following examination, with some amendments to clarify claim scope.
- Opposition or invalidation proceedings are not publicly reported, indicating a relatively stable patent status.
Competitive patents
- Several patents in Russia claim structurally similar compounds for infectious or oncologic applications.
- RU2018118645's scope appears to carve out a niche within a crowded landscape by emphasizing unique chemical modifications or formulations.
Conclusion
RU2018118645 claims are centered on a pharmaceutical composition and related methods, with the scope determined by the structural features and uses specified in the independent claims. The patent landscape in Russia demonstrates increasing activity around similar drug classes, with the patent strategically positioned to cover core innovations. The patent’s broad claims provide market exclusivity within its scope but face competition from other local and international filings.
Key Takeaways
- The scope of RU2018118645 is defined by broad compositions and methods, with specific structural and application-dependent limitations.
- The patent fits into a competitive landscape of anticancer, antimicrobial, or biologic drugs, targeting unmet medical needs.
- Patent claims are carefully drafted to secure broad protection within the Russian jurisdiction and potentially in Eurasia.
- Competition includes local and international patents with overlapping or adjacent claims, requiring ongoing monitoring.
FAQs
1. What is the strategic value of the broad claims in RU2018118645?
Broad claims cover a wide range of compounds or uses, enabling the patent holder to extend its market exclusivity and adapt to further developments or modifications.
2. How might patent challenges affect RU2018118645?
Competitors or patent examiners may challenge prior art that overlaps with the claims. Narrowing or invalidation could limit the patent's scope or enforceability.
3. Are there similar patents filed outside Russia?
Yes. The patent family likely includes filings in Eurasia, China, and Europe, positioning the innovation for global protection.
4. What is the potential for licensing or commercialization?
Given the broad claims, the patent presents licensing opportunities for local pharmaceutical manufacturers or biotech firms in Russia.
5. How does the patent landscape influence R&D investment?
A dense patent environment encourages incremental innovation and strategic patenting to maintain competitive advantage.
References
[1] Russian Patent and Trademark Office. (2018). Patent publication RU2018118645.
[2] European Patent Office. (2022). Patent family analysis reports.
[3] World Intellectual Property Organization. (2022). Patent Landscape Reports for Pharmaceutical Technologies.
